Supplementary Table 1.docx (21.43 kB)
Download file

imt-2021-0013 - Supplementary Material - Ruxolitinib, a JAK1/JAK2 selective inhibitor, ameliorates acute and chronic steroid-refractory GvHD mouse models

Download (21.43 kB)
posted on 08.09.2021, 10:52 by Figshare Future Science GroupFigshare Future Science Group, Eduardo Huarte, Michael Peel, Ashish Juvekar, Philip Dubé, Sarala Sarah, Lynn Stephens, Becky Stewart, Brian Long, Philip Czerniak, Julian Oliver, Paul Smith

Supplementary Table 1. Assessment of GvHD – standard GvHD scoring protocol [18].


Incyte Corporation